HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis.

Abstract
The Publisher regrets that this article is an accidental duplication of an article that has already been published in Transplant Proc. 2018; 50 (10):3739-3747, https://doi.org/10.1016/j.transproceed.2018.08.018. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
AuthorsK H C Li, J C S Ho, B Recaldin, M Gong, J Ho, G Li, T Liu, W K K Wu, M C S Wong, Y Xia, M Dong, G Tse, International Health Informatics Study (IHIS) Network
JournalTransplantation proceedings (Transplant Proc) Vol. 50 Issue 10 Pg. 3739-3747 (12 2018) ISSN: 1873-2623 [Electronic] United States
PMID30577265 (Publication Type: Journal Article)
CopyrightCopyright © 2018. Published by Elsevier Inc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: